References

Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050

10.1016/j.ophtha.2016.01.006 · 2016 · External reference

Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling

10.1136/bjophthalmol-2017-311266 · 2018 · External reference

Sustainability in health care by allocating resources effectively (SHARE) 10: operationalising disinvestment in a conceptual framework for resource allocation

10.1186/s12913-017-2506-7 · 2017 · External reference

Low-concentration atropine for myopia proression (LAMP) study: a randomized, double-blinded, placebo-controlled trial of 0.05%, 0.025%, and 0.01% atropine eye drops in myopia control

10.1016/j.ophtha.2018.05.029 · 2019 · External reference

Efficacy and safety of 8 atropine concentrations for myopia control in children: a network meta-analysis

10.1016/j.ophtha.2021.10.016 · 2022 · External reference

Repeated low-level red-light therapy for controlling onset and progression of myopia-a review

10.7150/ijms.85746 · 2023 · External reference

Optical strategy utilizing contrast modulation to slow myopia

10.1016/j.xops.2024.100672 · 2024 · External reference

Interventional modalities for the prevention and management of childhood myopia in frontiers in ophthalmology: PREC strategy for myopia in children

10.3389/fopht.2026.1740349 · 2026 · External reference